Scale-Out and -Up Strategies
Efficient and effective scale-up of production for viral vectors and allogeneic cell therapies and scale-out of production for autologous cell therapies; everyone agrees that these are absolutely key to the development of commercially viable products. But how can CoGs be controlled in practice? And what’s the optimal timing to start working on scale-up or scale-out? This spotlight will include plenty of real-life examples, as well as the latest thinking from those leading the field, to help you define the right strategy for your product.
COMING IN NOVEMBER 2017